出处
《中华神经科杂志》
CAS
CSCD
北大核心
2006年第6期421-423,共3页
Chinese Journal of Neurology
基金
中国博士后科学基金资助项目(2005037382)
参考文献19
-
1Colciaghi F,Marcello E,Borroni B,et al.Platelet APP,ADAM 10 and BACE alterations in the early stages of Alzheimer disease.Neurology,2004,62:498-501.
-
2Stein TD,Anders NJ,DeCarli C,et al.Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSW mice resulting in tau phosphorylation and loss of hippocampal neurons:support for the amyloid hypothesis.J Neurosci,2004,4:7707-7717.
-
3Hooper NM,Parvathy S,Karran EH,et al.Angiotensin-converting enzyme and the amyloid precursor protein secretases.Biochem Soc Trans,1999,27:229-234.
-
4Asai M,Hattori C,Szabo B,et al.Putative function of ADAM9,ADAM10,and ADAM17 as APP alpha-secretase.Biochem Biophys Res Commun,2003,301:231-235.
-
5Kojro E,Fahrenholz F.The non-amyloidogenic pathway:structure and function of alpha-secretases.Subcell Biochem,2005,38:105-127.
-
6Di Luca M,Grossi E,Borroni B,et al.Artificial neural networks allow the use of simultaneous measurements of Alzheimer disease markers for early detection of the disease.J Transl Med,2005,3:30.
-
7Kojro E,Gimpl G,Lammich S,et al.Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10.Proc Natl Acad Sci USA,2001,98:5815-5820.
-
8Hartmann D,de Strooper B,Serneels L,et al.The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts.Hum Mol Genet,2002,11:2615-2624.
-
9Hotoda N,Koike H,Sasagawa N,et al.A secreted form of human ADAM9 has an alpha-secretase activity for APP.Biochem Biophys Res Commun,2002,293:800-805.
-
10Fahrenholz F,Gilbert S,Kojro E,et al.Alpha-secretase activity of the disintegrin metalloprotease ADAM 10.Influences of domain structure.Ann N Y Acad Sci,2000,920:215-222.
二级参考文献17
-
1Querfurth HW, Jiang J, Geiger JD, et al. Caffeine stimulates amyloid beta - peptide release from beta - amyloid precursor protein - transfected HEK293 cells. J Neurochem, 1997, 69(4) : 1580- 1591.
-
2Nitsch RM, Deng M, Growdon JH, et al. Serotonin 5 - HT2a and 5 -HT2c receptors stimulate amyloid precursor protein ectodomain secretion. J Biol Chem, 1996, 271(8):4188-4194.
-
3Desdouits - Magnen J, Desdouits F, Takeda S, et al. Regulation of secretion of Alzheimer amyloid precursor protein by the mitogen-activated protein kinase cascade. J Neurochem, 1998, 70(2): 524-530.
-
4Yogev - Falach M, Amit T, Bar - Am O, et al. Involvement of MAP kinase in the regulation of amyloid precursor protein processing by novel cholinesterase inhibitors derived from rasagiline. FASEB J, 2002, 16(12): 1674- 1676.
-
5Solano DC, Sironi M, Bonfini C, et al. Insulin regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase-dependent pathway. FASEB J, 2000, 14(7) : 1015 - 1022.
-
6Mudher A, Chapman S, Richardson J, et al. Dishevelled regulates the metabolism of amylold precursor protein via protein kinase C/mitogen-activated protein kinase and c-Jun terminal kinase. J Neursci, 2001,21 (14) : 4987 - 4995.
-
7Yamatsuji T, Okamoto T, Takeda S, et al. Expression of V642 APP mutant causes cellular apoptosis as Alzheimer trait - linked phenotype.EMBO J, 1996, 15(3) : 498 - 509.
-
8Mbebi C, See V, Mercken L, et al. Amyloid precursor protein family-induced neuronal death is mediated by impairment of the neuroprotective calcium/calmodulin protein kinase Ⅳ- dependent signaling pathway. J Biol Chem, 2002, 277(23) : 20979 - 20990.
-
9Cheng G, Yu Z, Zhou D, et al. Phosphatidylinositol - 3 - kinase - Akt kinase and p42/p44 mitogen - activated protein kinases mediate neurotrophic and excitoprotective actions of a secreted form of amyloid precursor protein. Exp Ncurol, 2002, 175(2) : 407 - 414.
-
10Luo Y, Sunderland T, Wolozin B. Physiologic levels of beta - amyloid activate phosphatidylinositol 3 - kinase with the involvement of tyrosine phosphorylation. J Neurochem, 1996, 67(3) : 978 - 987.
同被引文献41
-
1魏翠柏,田金洲,贾建平.老年痴呆中医病因病机理论的认识与思考[J].中华中医药杂志,2005,20(8):496-498. 被引量:82
-
2Wolfe MS.gamma-Secretase in biology and medicine.Semin Cell Dev Biol,2009,20:219-224.
-
3Selkoe DJ,Wolfe MS.Presenilin:running with scissors in the membrane.Cell,2007,131:215-221.
-
4De Strooper B.Aph-1,Pen-2,and Nicastrin with Presenilin generate an active gamma-Secretase complex.Neuron,2003,38:9-12.
-
5Spasic D,Annaert W.Building gamma-secretase:the bits and pieces.J Cell Sci,2008,121 Pt4:413-420.
-
6Kimberly WT,LaVoie MJ,Ostaszewski BL,et al.Gammasecretase is a membrane protein complex comprised of presenilin,nicastrin,Aph-1,and Pen-2.Proc Natl Acad Sci U S A,2003,100:6382-6387.
-
7Steiner H,Winkler E,Haass C.Chemical cross-linking provides a model of the gamma-secretase complex subunit architecture and evidence for close proximity of the C-terminal fragment of presenilin with APH-1.J Biol Chem,2008,283:34677-34686.
-
8Francis R,McGrath G,Zhang J,et al.aph-1 and pen-2 are required for Notch pathway signaling,gamma-secretase cleavage of betaAPP,and presenilin protein accumulation.Dev Cell,2002,3:85-97.
-
9Shirotani K,Edbauer D,Prokop S,et al.Identification of distinct gamma-secretase complexes with different APH-1 variants.J Biol Chem,2004,279:41340-41345.
-
10Ma G,Li T,Price DL,et al.APH-1a is the principal mammalian APH-1 isoform present in gamma-secretase complexes during embryonic development.J Neurosci,2005,25:192-198.
引证文献3
-
1汪克建,龙志敏,高宝兵,赵蕾,陆蔚天,甘胜伟,贺桂琼.蛋白酶体抑制剂对神经细胞前咽缺陷蛋白-1表达的影响[J].中华神经科杂志,2010,43(11):795-800.
-
2吴宿慧,李寒冰,陈晓晖,李根林.胰岛素/胰岛素样生长因子信号通路:“整合效应”治疗阿尔茨海默病潜在途径及人参的治疗特点及优势[J].中国老年学杂志,2018,38(23):5867-5871. 被引量:9
-
3徐梓茗.老年人血管相关病变对阿尔茨海默病发病风险的影响[J].中国医学工程,2015,23(2):200-201.
二级引证文献9
-
1阎茹玉,吴宿慧,方亚影,赵丹丹,单艳玲,李寒冰,李根林.原人参二醇延缓衰老及抗氧化应激作用的机制研究[J].中药药理与临床,2022,38(1):56-62. 被引量:7
-
2叶杰,于晓丽,王妍,于晓焕.家族性遗传预防对降低阿尔茨海默病老年患者发病率的影响[J].中国老年学杂志,2019,39(24):6049-6052. 被引量:3
-
3李根林,张露露,吴宿慧,李寒冰,王凤娟,吕依妍.基于脑内能量调节的人参对东莨菪碱致痴呆小鼠记忆障碍改善作用[J].中药药理与临床,2020,36(1):99-104. 被引量:8
-
4赵琳琳,丁婧,曲扬,杨滨瑞,高腾,张惊宇.葡萄糖代谢异常与阿尔茨海默病发病机制的研究进展[J].中国实验诊断学,2020,24(6):1057-1059. 被引量:4
-
5郭园园,郑琴,胡鹏翼,杨明,章德林,唐宇,罗俊,朱梅芳,吴海霞,吴玲,张科楠.中药调控能量代谢治疗神经退行性疾病的研究进展[J].中药新药与临床药理,2020,31(11):1384-1388. 被引量:9
-
6张宇亮,李仁杰,董成林,徐灵,李婉青,曾金明,蒋茴茴.三磷酸腺苷结合盒转运蛋白7在阿尔茨海默病患者血清中表达及其与疾病预后的关系[J].实用医院临床杂志,2021,18(1):34-37. 被引量:7
-
7吴宿慧,张晗,张宇航,牛婷媛,李寒冰,高剑峰,李根林.沙利度胺对Aβ_(1-42)致AD模型小鼠的海马蛋白质组学影响[J].中国药理学通报,2023,39(2):315-325.
-
8武峻艳,李星,王杰,尹炳琪,顾昕怡.针刺对阿尔茨海默病大鼠海马区胰岛素PI3K/Akt信号通路及葡萄糖代谢的影响[J].中华中医药学刊,2023,41(8):51-55. 被引量:4
-
9陈曦,李玉姣,赵岚.microRNA-124在阿尔兹海默症中的作用及针刺干预研究进展[J].天津中医药大学学报,2024,43(1):64-70. 被引量:1
-
1周婷,于艳,孙邈,张希朦,尹晨,崔德华.阿尔茨海默病的干预与α分泌酶ADAM10[J].神经疾病与精神卫生,2010(6):541-545. 被引量:1
-
2刘宇,赵江浩,尹明康,黄鹏如,蔡玉洁,崔理立,李克深,赵斌.α分泌酶在阿尔茨海默病中的研究进展[J].吉林医学,2016,37(4):944-948. 被引量:3
-
3罗焕敏,谷峰.β淀粉样蛋白的分泌酶与阿尔采末病的治疗[J].生理科学进展,2003,34(2):189-192. 被引量:4
-
4何池忠,刘新通,王丽娟,张雄,徐书雯,莫建伟,李东风.轻度认知障碍患者血小板中α、β-分泌酶基因表达水平及其临床意义[J].卒中与神经疾病,2012,19(4):195-198.
-
5周奕.α分泌酶在阿尔茨海默病治疗中的效果分析[J].生物技术世界,2015,12(8):154-154.
-
6柯荔宁,王玮.缺氧缺血环境中的小胶质细胞介导的反应[J].医学综述,2008,14(1):27-30. 被引量:9
-
7王钢,袁琛,赵荣诚.阿司匹林抵抗的发生机制[J].医学综述,2009,15(6):829-831.
-
8王军锋,路睿,王以政.Regulation of β cleavage of amyloid precursor protein[J].Neuroscience Bulletin,2010,26(5):417-427. 被引量:1
-
9杨红旗,孙治坤,蒋秋焕,尚茜,徐军.雌二醇对大鼠皮质原代神经元α分泌酶活性的影响[J].郑州大学学报(医学版),2009,44(5):999-1003. 被引量:5
-
10余兰,熊念,王涛.线粒体DNA与帕金森病关系的研究进展[J].卒中与神经疾病,2012,19(2):120-122. 被引量:3